Tag: raw materials

Assessing Functional Performance Failures During Scale-Up: An Investigative Approach Functional performance failures during scale-up can present significant challenges in pharmaceutical manufacturing, particularly concerning excipient selection and compatibility. Such failures can…

Investigating Functional Performance Failures During Regulatory Review of Excipient Data Functional performance failures during regulatory review can lead to scrutiny over excipient data, impacting your manufacturing processes and compliance standing.…

Assessing the Risks of Supplier Grade Substitution in Excipient Selection In the pharmaceutical industry, the selection of excipients plays a critical role in ensuring the quality and efficacy of final…

Understanding Variability in Excipient Grade During Supplier Qualification: A Comprehensive Investigation In the pharmaceutical industry, variability in excipient grade during supplier qualification can lead to significant impacts on product quality…

Overlooked Moisture Sensitivity During Regulatory Reviews: Ensuring Compatibility Studies Meet Expectations The pharmaceutical industry operates under stringent regulations where the integrity of raw materials, particularly excipients and active pharmaceutical ingredients…

Examining Supplier Grade Substitution During Formulation Development: Expectations for Compatibility Studies In the pharmaceutical landscape, the substitution of excipients or active pharmaceutical ingredients (APIs) during formulation development presents a complex…

Investigating Unjustified Excipient Choice During Supplier Qualification In the pharmaceutical industry, the choice of excipients is critical to ensuring the quality, safety, and efficacy of the final product. An unjustified…

Addressing Functional Performance Failures during Supplier Qualification: A Comprehensive Investigation Approach In the pharmaceutical industry, ensuring the quality and compatibility of excipients during supplier qualification is critical for maintaining product…

Assessing the Risks of Unjustified Excipient Choices in Formulation Development In the pharmaceutical industry, excipients play a critical role in drug formulation, impacting API quality and overall product efficacy. However,…

Addressing Functional Performance Failures During Scale-Up: An Investigation Guide In the fast-paced world of pharmaceutical manufacturing, functional performance failures during scale-up can pose significant risks, particularly when they necessitate late-stage…

Understanding Functional Performance Failures During Scale-Up: Navigating Regulatory Expectations Functional performance failures during the scale-up of pharmaceutical manufacturing processes can not only derail production timelines but also trigger significant regulatory…

Understanding the Impact of Unverified Excipient Selection During Supplier Qualification Pharmaceutical manufacturers must remain vigilant in their choice of excipients, as unjustified selections can lead to significant compatibility issues and…